Chemistry: molecular biology and microbiology – Maintaining blood or sperm in a physiologically active state...
Patent
1995-08-29
2000-09-05
Wortman, Donna C.
Chemistry: molecular biology and microbiology
Maintaining blood or sperm in a physiologically active state...
435238, 604416, A01N 102, C12N 706
Patent
active
061141089
ABSTRACT:
The means and methods of inactivating viruses and other organisms in cell-containing or biopolymer-containing compositions comprising contacting such compositions with selective ethyleneimine oligomer inactivating agents are disclosed. The means and methods of this invention selectively modify functional nucleic acids in a cell-containing or biopolymer-containing composition using selective ethyleneimine oligomer inactivating agents, such as the trimer or tetramer without significant alteration of proteins or other biopolymers.
REFERENCES:
patent: 3492289 (1970-01-01), Symm et al.
patent: 4036952 (1977-07-01), Bauer et al.
patent: 4058599 (1977-11-01), Bauer et al.
patent: 4841023 (1989-06-01), Horowitz
patent: 5000951 (1991-03-01), Bass et al.
patent: 5055485 (1991-10-01), Geacintov et al.
patent: 5120649 (1992-06-01), Horowitz et al.
patent: 5232844 (1993-08-01), Horowitz et al.
Henry, J.B., ed., Clinical Diagnosis and Management by Laboratory Methods, W.B. Saunders Company, Philadelphia, 1991.
Bahnemann, H.G., "Inactivation of Viruses in Serum with Binary Ethyleneimine", Journal of Clinical Microbiology, vol. 3, No. 2, pp. 209-210 (1975).
Budowsky et al., "Inactivation of the phage MS2 infectivity by the action of ethyleneimines," Biorg. Khim. 11:989-991 (1985) (in Russian). English translation provided, 3 pages.
Tanirbergenov, T.B. et al., "Regularities of mutagenic and toxic effects of ethyleneimine and its oligomers. A comparative study in the automated system SOS-chromotest and in standard bacterial test systems," Genetika 24:763 (1988) (in Russian). English translation provided, 5 pages.
Bahnemann, H.G., "Inactivation of Viral Antigens for Vaccine Preparation with Particular Reference to the Application of Binary Ethylenimine", Vaccine, 8:299-303 (1990).
Race, E. et al., "An Experimental Chemically Inactivated HIV-1 Vaccine Induces Antibodies that Neutralize Homologous and Heterologous Viruses", Vaccine, 13:1 pp. 54-60 (1995).
Budowsky, E.I. et al., "Principles of Selective Inactivation of the Viral Genome: Dependence of the Rate of Viral RNA Modification of the Number of Protonizable Groups in Ethyleneimine Oligomer", Vaccine Research, 5:1 pp. 29-39 (1996).
Kostyanovskii, R.G. et al. (Translated from Izvestiya Akademi Nauk SSSR, Seriya Khimicheskaya, 11:2566-2577, 1988).
Van Etten, R.L. and Dolhum, J.J. (1968) J. Org. Chem. 33:3904-3913.
Earley, J.E. et al. (1958) J. Am Chem. Soc. 80:3458-3462.
Dermer, O.C. and Ham, G.E. (1969) Ethyleneimine And Other Aziridines, Acad. Press, NY--London 52:249-285.
Budowsky, E.I. and Zalesskaya, M.A. (1991) Principles of selective inactivation of viral genome. v. Rational selection of conditions for inactivation of the viral suspension infectivity to a given extent by the action of B-propiolactone. Vaccine, (9:319-325).
Kochetov, N.K. and Budowsky, E.I. eds. (1972) p.48-55, Organic Chemistry of Nucleic Acids, Part B, Plenum Press, London-New York.
Brumback Brenda
V.I. Technologies, Inc.
Wortman Donna C.
LandOfFree
Methods and compositions for the selective modification of viral does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for the selective modification of viral, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for the selective modification of viral will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2210844